Seeing Is Believing
Currently out of the existing stock ratings of Laura Sutcliffe, 27 are a BUY (50%), 27 are a HOLD (50%).
Analyst Laura Sutcliffe, currently employed at CITI, carries an average stock price target met ratio of 43.25% that have a potential upside of 24.7% achieved within 354 days.
Laura Sutcliffe’s has documented 100 price targets and ratings displayed on 11 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on RMD, ResMed at 13-Jul-2026.
Analyst best performing recommendations are on RMD (RESMED).
The best stock recommendation documented was for GLPG (GALAPAGOS NV ADR) at 5/18/2020. The price target of $217.34 was fulfilled within 3 days with a profit of $5.27 (2.37%) receiving and performance score of 7.89.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 16-Oct-2020
$33
$4.87 (17.31%)
$32
7 months 29 days ago
(25-Feb-2026)
17/19 (89.47%)
$-1.02 (-3.00%)
59
Hold Since 09-Sep-2024
$40
$11.87 (42.20%)
$24
1 years 3 days ago
(21-Oct-2025)
1/2 (50%)
$8.57 (27.27%)
127
Hold Since 07-Mar-2024
$22
$-6.13 (-21.79%)
$31
1 years 8 months 10 days ago
(14-Feb-2025)
3/6 (50%)
$-3.44 (-13.52%)
376
Hold Since 19-Jan-2021
$125
1 years 9 months 1 days ago
(23-Jan-2025)
1/2 (50%)
$17.27 (16.03%)
63
Hold Since 14-Oct-2022
1 years 9 months 1 days ago
(23-Jan-2025)
2/6 (33.33%)
$2.78 (6.01%)
28
Which stock is Laura Sutcliffe most bullish on?
Which stock is Laura Sutcliffe most reserved on?
What Year was the first public recommendation made by Laura Sutcliffe?